Does the pharmaceutical industry influence guidelines?: two examples from Germany. - Wikidata - wikimedia - TriplyDB

Does the pharmaceutical industry influence guidelines?: two examples from Germany.

Does the pharmaceutical industry influence guidelines?: two examples from Germany.

http://www.wikidata.org/entity/Q37199193

about

When should acute exacerbations of COPD be treated with systemic corticosteroids and antibiotics in primary care: a systematic review of current COPD guidelines Declaration and Handling of Conflicts of Interest in Guidelines: A Study of S1 Guidelines From German Specialist Societies From 2010-2013 The relationship between the physician and pharmaceutical industry: background ethics and regulation proposals Transparency is key.Manipulated evidence?Information advantage or conflicts of interest?No robust argument.Confirming the hypothesis at any cost?Conflicts of interest--an ever present challenge.Management of financial conflicts of interests in clinical practice guidelines in Germany: results from the public database GuidelineWatch.

P2860

Q28085429-19AFDD38-8ADB-4813-B7E2-5F50126F6649 Q35891271-6E66B91C-6769-4809-ABE4-68E1E72588FF Q37307255-82ECFD1A-2DB8-45DD-9354-B355D6512A4B Q42413450-0594808F-237F-46F0-8C13-492ED22F7DE4 Q42413453-A6B3B046-46A7-439E-8AF5-3B24D08A4AE3 Q42413457-E308D73F-A6B1-4454-88CF-C8D21330A7FF Q42413460-EA9A1EA6-669E-4C39-9FA7-511094C09366 Q42413461-94A812D6-1B77-4372-8606-E7D95FBEC0DD Q42965860-E53153B3-B7F1-4D77-A4F8-D7332AEDCECC Q55514011-63939D26-0CF3-4827-A362-BE60C7F0B0E6

P2860

Does the pharmaceutical industry influence guidelines?: two examples from Germany.

http://www.wikidata.org/entity/Q37199193

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Does the pharmaceutical industry influence guidelines?: two examples from Germany.

@en

Does the pharmaceutical industry influence guidelines?: two examples from Germany.

@nl

type

label

Does the pharmaceutical industry influence guidelines?: two examples from Germany.

@en

Does the pharmaceutical industry influence guidelines?: two examples from Germany.

@nl

prefLabel

Does the pharmaceutical industry influence guidelines?: two examples from Germany.

@en

Does the pharmaceutical industry influence guidelines?: two examples from Germany.

@nl

P1433

Q37199193-4DC9B5BF-CD5B-40B1-823A-554B8AEEDB6B

P1476

Q37199193-712258CD-A204-4AC8-8BD2-D62141E9E272

P2093

Q37199193-193936A6-B507-47D2-9C84-0A02B07F7689

Q37199193-49951647-AA80-4D69-87E7-F96EDAB3E56B

Q37199193-5A37D427-23DB-4018-99B5-95AA15749F94

Q37199193-7264414E-A67E-4968-9EE6-C7D8B8E5410F

Q37199193-74DA586D-D2A5-4233-A7D6-39F97F852CBF

Q37199193-7F014796-FA2C-47FB-A9AD-5BD4EC6D1F45

P2860

Q37199193-19C1B3D5-1C33-45FC-A0DF-35C7F688E342

Q37199193-2508E7CB-F5D4-44B6-99E4-E072E12F0F00

Q37199193-25FC2114-C191-47F0-812A-9C19EDFAE738

Q37199193-288FE414-DD5F-49A3-958A-F012D8EF3BFD

Q37199193-2AD674A7-F961-4BB5-834F-FEEFD3A6BE90

Q37199193-32A5B758-E514-4E30-9753-6E6F212D245F

Q37199193-43C8DA63-6FF1-42EF-8EC9-6F6F95D1C039

Q37199193-47F60EEF-D579-438D-B3BA-6B5BF52A8344

Q37199193-4F8177A1-6FC0-4C73-AAA5-EB98825FE72F

Q37199193-516C635C-D658-47E8-85CC-D6E61BEA05CA

P304

Q37199193-3C391AA1-A0F1-4AC5-A7BB-8AFFE5AFB25C

P31

Q37199193-BD0ECE53-E778-4291-B03A-50C753072609

P356

Q37199193-92F9B62B-8BA7-4AB0-9972-7111048F03AC

P433

Q37199193-591350F2-9EF2-4C62-AFDD-EB87273F2DC5

P478

Q37199193-A3E4C669-FA65-4BB2-B9CB-1BC2464580B4

P577

Q37199193-896908C4-D07C-49E4-9207-239C746BF618

P5875

Q37199193-50AC19B1-1912-40C6-864F-201590507F86

P698

Q37199193-6D8510DD-234E-488B-8184-D684940D65D4

P921

Q37199193-3796FBB3-6E4F-45B5-99B9-A32E19F65AEF

P932

Q37199193-50221CB8-9EDA-43ED-8207-FA01E883D665

P356

ARZTEBL.2013.0575

P1433

Deutsches Ärzteblatt international

P1476

Does the pharmaceutical industry influence guidelines?: two examples from Germany.

@en

P2093

Bernd Mühlbauer

http://www.w3.org/2001/XMLSchema#string

Claudia Dünnweber

http://www.w3.org/2001/XMLSchema#string

Gisela Schott

http://www.w3.org/2001/XMLSchema#string

Henry Pachl

http://www.w3.org/2001/XMLSchema#string

Wilhelm Niebling

http://www.w3.org/2001/XMLSchema#string

Wolf-Dieter Ludwig

http://www.w3.org/2001/XMLSchema#string

P2860

Gabapentin for acute and chronic pain

Gabapentin for acute and chronic pain

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions

Financial ties between DSM-IV panel members and the pharmaceutical industry

Outcome reporting in industry-sponsored trials of gabapentin for off-label use

Differences in reporting of analyses in internal company documents versus published trial reports: comparisons in industry-sponsored trials in off-label uses of gabapentin

Scope and impact of financial conflicts of interest in biomedical research: a systematic review

The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication.

Efficacy of gabapentin in migraine prophylaxis.

P304

575-583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3238/ARZTEBL.2013.0575

http://www.w3.org/2001/XMLSchema#string

P433

35-36

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257206363

http://www.w3.org/2001/XMLSchema#string

P698

24078837

http://www.w3.org/2001/XMLSchema#string

P921

P932

3783818

http://www.w3.org/2001/XMLSchema#string